Health Research — Map of Content

Personal health research vault. Cross-referenced notes covering iron metabolism, neurodevelopment, mineral interactions, gut-brain axis, and clinical management.
Patient: Anthony G. | Age: 37 | Key conditions: AuDHD (ADHD-PI + Autism), Trichotillomania, HFE C282Y/H63D compound heterozygote

New here? Start with the Partner Guide — a plain-language summary of what's going on, why I struggle, and how you can help.

Lab Results

Genetics

Iron Metabolism

Neurodevelopment

Gut-Brain Axis

Minerals

Sleep

Body Systems

Exercise

Neuroprotection

Symptoms

Practical Management

Research Meta


Key Findings from PubMed Verification (March 2026)

The following findings were verified against PubMed and OpenAlex on 2026-03-22, confirming their citations exist and conclusions are accurately represented:

  1. Chang 2014 (HFE iron overload mice): Iron overload in HFE-model mice produces repetitive behaviour and dopamine disruption in the basal ganglia, providing direct mechanistic evidence that excess brain iron drives stereotyped behaviours relevant to trichotillomania
  2. Grotzinger 2025 (cross-disorder GWAS): Mapping genetic architecture across 14 psychiatric disorders (n=1,056,201 cases) identified five genomic factors explaining ~66% of genetic variance and 238 pleiotropic loci — ADHD and autism load onto shared factors, with shared signal enriched in excitatory neurons. See Genetic Architecture of AuDHD
  3. Iron overload causes gut dysbiosis AND cognitive impairment (PMID 39438708): Suparan et al. demonstrated that iron overload causes cognitive impairment via the gut-brain axis, with association between gut/blood microbiome alterations, cognition, and iron burden. See Gut-Brain Axis and Neurodevelopment
  4. Jiang 2024 (System Xc- ferroptosis in autism models): Ferroptosis via the System Xc-/GPX4 pathway is implicated in autism models, linking iron-dependent cell death to glutamate dysregulation. See research/Ferroptosis and Neuronal Iron
  5. Memantine RCT: 60.5% vs 8.3% for TTM (Grant 2023): Double-blind placebo-controlled study of memantine in 100 adults with TTM/skin-picking showed 60.5% improvement vs 8.3% placebo (NNT=1.9), providing strong confirmation of the glutamate hypothesis for BFRBs alongside the NAC evidence. See Trichotillomania and Neurodevelopmental Links
  6. Brancati 2025 ("Hidden phenotype"): Found that 21.9% of adults with ADHD screened positive for ASD, with higher age at first clinical referral, greater emotional dysregulation, more mood/anxiety comorbidity, and evening chronotype — describing the "hidden phenotype" of autism in adults diagnosed with ADHD. See Late-Diagnosed Autism - Distinct Profile
  7. No PubMed study exists on stimulant-mediated autism unmasking: Despite clinical recognition of this phenomenon, no peer-reviewed study has directly investigated stimulant medication unmasking autistic traits — this remains an evidence gap supported only by clinical observation and grey literature
  8. East et al. (infant iron deficiency predicts SCT/CDS): Infant iron deficiency predicted SCT/CDS symptoms in childhood and adolescence, establishing an early developmental link between iron status and cognitive disengagement. See ADHD-PI and Internal Hyperactivity
  9. Mitchell 2009 (H63D and glutamate): H63D HFE cells show directly increased glutamate release and reduced glutamate uptake capacity, demonstrating that Anthony's H63D variant may promote glutamate excitotoxicity — the same pathway implicated in trichotillomania and targeted by NAC. See Genetic Architecture of AuDHD

How to Use This Vault

  1. Start here for an overview, then follow wikilinks into topics
  2. Each note has a Cross-References section at the bottom linking to related notes
  3. Use Obsidian's Graph View to visualise connections between topics
  4. The Action Items and Monitoring Plan note contains practical next steps
  5. The research/Research Avenues Tracker tracks research leads and their status
  6. The Diet and Supplement Strategy note contains the supplement protocol
  7. Update Blood Results - March 2026 with future test results to track progress

Key Themes Across Notes

1. Iron Overload Cascade

How HFE drives downstream damage through five pathways.

Colour key: 🟣 Genetics | 🔴 Iron pathway / mechanism | 🟡 Symptom endpoint

flowchart TD
    classDef gen fill:#d2b4de,stroke:#7d3c98,color:#1a0422
    classDef iron fill:#f1948a,stroke:#c0392b,color:#1a0505
    classDef out fill:#f7dc6f,stroke:#b7950b,color:#1a1400

    A[HFE C282Y / H63D]:::gen --> B[Iron Overload]:::iron
    B --> C[NTBI + Oxidative Stress]:::iron
    B --> I[Brain Iron]:::iron
    B --> N[Gut Dysbiosis]:::iron

    C --> E[Fatigue + Joint Damage]:::out
    C --> GSH[GSH Depletion]:::iron
    GSH --> FPT[Ferroptosis]:::out
    GSH --> GLU[Glutamate Excess]:::out

    I --> ADHD[ADHD Symptoms]:::out
    I --> TTM[Trichotillomania]:::out
    I --> ASD[Autism Symptoms]:::out

    N --> KYN[Kynurenine Shunt]:::iron
    KYN --> TTM
    KYN --> SLP[Poor Sleep]:::out

    B --> TEST[Low Testosterone]:::out

2. Sleep as Central Amplifier

Poor sleep feeds back into every other system, creating vicious cycles.

Colour key: 🔵 Sleep mechanism | 🔴 Feeds back into iron/inflammation | 🟡 Symptom endpoint

flowchart TD
    classDef sleep fill:#85c1e9,stroke:#2471a3,color:#0a1929
    classDef out fill:#f7dc6f,stroke:#b7950b,color:#1a1400
    classDef feed fill:#f1948a,stroke:#c0392b,color:#1a0505

    R[Poor Sleep]:::sleep

    R --> AH[Low Glymphatic Clearance]:::sleep
    R --> AI[Gut Dysbiosis]:::sleep
    R --> AJ[Low Executive Function]:::sleep
    R --> AK[DA Downregulation]:::sleep
    R --> AL[Sensory Amplification]:::sleep
    R --> AM[High Cortisol]:::sleep
    R --> FPT[Ferroptosis Acceleration]:::sleep

    AH --> BI[Brain Iron]:::feed
    AI --> IDO[IDO Activation]:::feed
    AM --> IDO
    AJ --> ADHD[ADHD Symptoms]:::out
    AJ --> TTM[Trichotillomania]:::out
    AK --> ADHD
    AL --> ASD[Autism Symptoms]:::out

    ADHD --> R
    ASD --> R
    MASK[Masking Cost]:::out --> R
    HYP[Internal Hyperactivity]:::out --> R
    ELV[Elvanse]:::out --> R
    AL -.-> R

3. Interventions and Targets

Dotted lines show protective effects.

Colour key: 🟢 Intervention | 🟠 Medication | 🔴 Target / problem

flowchart LR
    classDef protect fill:#58d68d,stroke:#1e8449,color:#0a1f12
    classDef med fill:#f0b27a,stroke:#ca6f1e,color:#1a1000
    classDef target fill:#f1948a,stroke:#c0392b,color:#1a0505

    subgraph TREAT ["Treatment"]
        M[Phlebotomy]:::protect
        L[Diet Changes]:::protect
        BA[Exercise]:::protect
        BB[NAC]:::protect
        AN[Melatonin]:::protect
        AO[Chronotherapy]:::protect
        AP[Sensory Optimisation]:::protect
    end

    subgraph MEDS ["Medication"]
        J[Elvanse 70mg]:::med
    end

    %% Phlebotomy targets
    M -.-> IO[Iron Overload]:::target
    M -.-> PIT[Pituitary Iron]:::target
    M -.-> TEST[Low Testosterone]:::target

    %% Diet targets
    L -.-> IO

    %% Exercise targets
    BA -.-> BI[Brain Iron]:::target
    BA -.-> DA[DA Downregulation]:::target
    BA -.-> SLP[Poor Sleep]:::target
    BA -.-> GUT[Gut Dysbiosis]:::target

    %% NAC targets
    BB -.-> GSH[GSH Depletion]:::target
    BB -.-> FPT[Ferroptosis]:::target
    BB -.-> GLU[Glutamate Excess]:::target
    BB -.-> TTM[Trichotillomania]:::target

    %% Sleep interventions
    AN -.-> SLP
    AO -.-> SLP
    AP -.-> SENS[Sensory Reactivity]:::target

    %% Elvanse effects
    J --> APP[Appetite Suppression]:::med
    APP -.-> CUZN[Cu / Zn Depletion]:::target
    J --> UNMASK[Autistic Unmasking]:::med

Citation Summary

All notes contain inline citations. Key journals referenced:


Disclaimer: This research vault is for personal information-tracking purposes. It does not constitute medical advice. All clinical decisions should be made with qualified healthcare professionals.